GO:0015026 coreceptor activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0015026 coreceptor activity describes a molecular function in which a protein binds an extracellular or intracellular messenger and, together with a nearby primary receptor, initiates a change in cell activity.
• Coreceptors do not act alone; they form ternary or higher-order complexes with primary receptors, as shown for FGF-FGFR-klotho and FGF-FGFR-heparan sulfate complexes.
• Coreceptor activity is essential for signal diversification and fine-tuning in development, immunity, coagulation, and metabolism.
• Dysregulated coreceptor function contributes to cancer, chronic kidney disease, cardiovascular disease, and inflammatory disorders.
• Coreceptors such as klotho, CD44, syndecan-2, and SCUBE proteins are attractive targets for functional genomics and therapeutic intervention.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable precise interrogation of coreceptor-dependent signaling pathways.
Description
Coreceptor activity (GO:0015026) is a molecular function that defines how certain cell-surface or secreted proteins cooperate with a primary receptor to transduce signals from extracellular or intracellular messengers. Unlike primary receptors that directly bind a ligand and initiate signaling, coreceptors often lack intrinsic catalytic activity and instead modulate ligand presentation, receptor conformation, or downstream effector recruitment. This cooperative mechanism is central to diverse biological processes, including fibroblast growth factor (FGF) signaling, immune cell activation, and hemostasis. Understanding coreceptor activity is therefore critical for researchers dissecting signal transduction networks and for developing targeted therapeutics. The QuickGO definition states that coreceptor activity involves combining with an extracellular or intracellular messenger and, in cooperation with a nearby primary receptor, initiating a change in cell activity. This definition captures the essence of a functional class of proteins that are increasingly recognized as key nodes in disease-associated pathways.
coreceptor activity At A Glance
| GO ID | GO:0015026 |
|---|---|
| GO term | coreceptor activity |
| Ontology | molecular_function |
| Synonym | coreceptor, insoluble ligand activity; coreceptor, soluble ligand activity |
| Major function | Cooperates with a primary receptor to bind a messenger and initiate a change in cell activity |
| Example coreceptors | Klotho, CD44, syndecan-2, SCUBE proteins, coagulation factors |
| Associated pathways | FGF signaling, ErbB signaling, chemokine signaling, coagulation cascade |
| Disease relevance | Cancer, chronic kidney disease, cardiovascular disease, inflammation |
What Is GO:0015026?
In our own words, coreceptor activity (GO:0015026) is the function of a protein that binds a signaling molecule (the messenger) and simultaneously associates with a primary receptor, thereby enabling or enhancing the initiation of a cellular response. The coreceptor itself may not signal autonomously; its role is to facilitate, stabilize, or modify the signal delivered by the primary receptor. This function can be mediated by membrane-anchored proteins, secreted cofactors, or soluble ligand-binding molecules that act in concert with receptors such as receptor tyrosine kinases, cytokine receptors, or G-protein-coupled receptors.
Why Is coreceptor activity Important in Cell Biology?
Coreceptor activity is important because it provides a layer of specificity and regulation that primary receptors alone cannot achieve. By forming complexes with primary receptors, coreceptors expand the repertoire of ligands that can be sensed, modulate signal strength and duration, and integrate inputs from multiple pathways. This functional versatility makes coreceptors central to developmental processes, tissue homeostasis, and immune responses, and their dysregulation is implicated in a wide range of human diseases.
• Coreceptors enable FGF hormones to signal through FGFRs in a tissue-specific manner, as exemplified by klotho family proteins.
• CD44 isoforms act as coreceptors for ErbB ligands and influence breast cancer progression.
• Syndecan-2 functions as a coreceptor in developmental signaling and is linked to cell adhesion and migration.
• SCUBE proteins modulate Hedgehog and other signaling pathways as secreted coreceptors.
• Chemokine coreceptors are essential for immune cell trafficking and activation.
• Coagulation factors can act as coreceptors to mediate cellular signaling beyond hemostasis.
• Coreceptor dysfunction is associated with chronic kidney disease and cardiovascular complications.
• Targeting coreceptor activity offers therapeutic opportunities in oncology and metabolic disorders.
• Coreceptors are attractive nodes for CRISPR functional genomics screens.
• Understanding coreceptor biology aids in the design of biologics that modulate receptor complexes.
Molecular Mechanism of coreceptor activity
Ligand binding and messenger recognition
In simple terms: The coreceptor first grabs the signaling molecule.
Coreceptors bind extracellular or intracellular messengers with varying affinities. For example, klotho proteins bind FGF23 and FGF21, thereby determining ligand specificity for FGFR activation. In the FGF-FGFR-klotho complex, klotho acts as a coreceptor that directly engages the FGF ligand and the primary receptor, forming a ternary signaling assembly. Similarly, CD44 isoforms can bind ErbB ligands and present them to ErbB receptors.
Primary receptor cooperation and complex assembly
In simple terms: The coreceptor and the main receptor join forces.
Upon ligand binding, the coreceptor undergoes conformational changes that promote its association with a nearby primary receptor. Structural studies of FGF hormone signaling reveal that klotho and heparan sulfate proteoglycans cooperate with FGFR to stabilize the ligand-receptor complex and initiate downstream phosphorylation. Syndecan-2 can act as a coreceptor for growth factors, facilitating receptor oligomerization and signaling. SCUBE proteins form complexes with Hedgehog ligands and receptors to modulate pathway activity.
Signal initiation and downstream transduction
In simple terms: The assembled complex sends a signal into the cell.
Once the coreceptor-primary receptor complex is formed, it triggers intracellular signaling cascades. In FGF signaling, this leads to FGFR autophosphorylation and activation of MAPK and PI3K pathways. Coagulation factor-mediated signaling through protease-activated receptors requires coreceptor functions of tissue factor and other factors, leading to changes in gene expression. Chemokine coreceptors facilitate G-protein-coupled receptor activation and immune cell migration.
Regulation and feedback
In simple terms: The cell controls how much coreceptor is available and active.
Coreceptor activity is regulated at multiple levels, including expression, post-translational modification, and shedding. For instance, klotho expression is modulated by vitamin D and inflammatory cytokines, affecting FGF23 signaling in kidney and cardiovascular tissues. CD44 isoforms are differentially recruited by ErbB ligands, and their expression is altered in breast cancer. Syndecan-2 can be shed from the cell surface, converting it from a membrane coreceptor to a soluble modulator.
Key Genes Involved in GO:0015026 coreceptor activity
The following genes encode proteins with established coreceptor activity or that participate in coreceptor complexes across major signaling pathways.
| Gene | Major Role | Research Relevance |
|---|---|---|
| KL | Klotho coreceptor for FGF23 and FGF21 | Chronic kidney disease, cardiovascular disease, aging |
| KLB | Beta-klotho coreceptor for FGF21 and FGF19 | Metabolic disease, bile acid regulation |
| CD44 | Coreceptor for ErbB ligands and hyaluronan | Breast cancer, inflammation, stem cell biology |
| SDC2 | Syndecan-2 coreceptor for growth factors | Development, cell adhesion, cancer |
| SCUBE1 | Secreted coreceptor for Hedgehog signaling | Developmental signaling, cancer |
| SCUBE2 | Secreted coreceptor for Hedgehog signaling | Developmental signaling, cancer |
| SCUBE3 | Secreted coreceptor for Hedgehog signaling | Developmental signaling, cancer |
| FGF23 | Ligand for klotho-FGFR coreceptor complex | Phosphate homeostasis, kidney disease |
| FGFR1 | Primary receptor cooperating with klotho | FGF signaling, development, cancer |
| FGFR4 | Primary receptor cooperating with beta-klotho | Metabolic disease, cancer |
| CXCR4 | Chemokine receptor with coreceptor functions | Immune cell trafficking, cancer metastasis |
| CCR5 | Chemokine receptor with coreceptor functions | HIV entry, inflammation |
| F3 (TF) | Tissue factor coreceptor for coagulation proteases | Coagulation signaling, inflammation |
| PROCR | Protein C receptor coreceptor | Coagulation, inflammation |
| IL2RA | Coreceptor for IL-2 signaling | Immune regulation, autoimmunity |
| IL2RB | Coreceptor for IL-2 signaling | Immune regulation, autoimmunity |
| IL2RG | Coreceptor for IL-2 signaling | Immune regulation, autoimmunity |
How Is coreceptor activity Regulated?
Coreceptor activity is regulated at the level of gene expression, alternative splicing, post-translational modifications, and proteolytic shedding. For example, klotho expression is influenced by vitamin D, FGF23, and inflammatory cytokines, which in turn modulate FGF23 signaling in kidney and cardiovascular tissues. CD44 isoforms are differentially recruited by ErbB ligands, and this recruitment is altered in breast cancer. Syndecan-2 can be shed from the cell surface by matrix metalloproteinases, converting it into a soluble modulator of signaling. Coagulation factor-mediated signaling is regulated by tissue factor pathway inhibitor and other anticoagulant mechanisms.
coreceptor activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| KL | Chronic kidney disease, cardiovascular disease | Klotho knockout mouse, kidney organoids |
| CD44 | Breast cancer, inflammation | CD44 knockout breast cancer cell lines, xenografts |
| SCUBE3 | Developmental disorders, cancer | SCUBE3 knockout zebrafish, cancer cell lines |
| CXCR4 | Cancer metastasis, immune disorders | CXCR4 knockout mice, T-cell lines |
| F3 | Thrombosis, inflammation | Tissue factor knockout mice, endothelial cells |
Coreceptor activity in cancer
Dysregulated coreceptor function contributes to cancer progression. CD44 isoforms act as coreceptors for ErbB ligands and are involved in breast cancer. SCUBE proteins modulate Hedgehog signaling, which is aberrantly activated in several cancers. Klotho and beta-klotho can influence FGF signaling in cancer cells, affecting proliferation and survival.
Coreceptor activity in kidney and cardiovascular disease
Klotho is a critical coreceptor for FGF23 in the regulation of phosphate and vitamin D metabolism. Reduced klotho expression is associated with chronic kidney disease and cardiovascular complications. FGF23-klotho signaling disorders lead to hyperphosphatemia and vascular calcification.
Coreceptor activity in inflammation and immunity
Chemokine coreceptors such as CXCR4 and CCR5 are essential for immune cell trafficking and activation. Coagulation factor-mediated signaling through coreceptors like tissue factor contributes to inflammation and thrombosis. Interleukin-2 receptor subunits function as coreceptors in immune regulation.
From coreceptor activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of coreceptor abolish ligand-induced signaling? | CRISPR knockout of coreceptor gene in cell lines |
| Does a point mutation in the ligand-binding domain affect coreceptor function? | CRISPR point mutation knock-in |
| Can a tagged coreceptor be used to track complex formation? | Knock-in of epitope-tagged coreceptor |
| Does overexpression of coreceptor enhance signaling? | Stable overexpression in HEK293 or cancer cells |
| Which genes modulate coreceptor-dependent pathways? | Genome-wide CRISPR library screening |
| How does coreceptor shedding affect signaling? | Knockout of sheddase or coreceptor, soluble coreceptor treatment |
How to Study the coreceptor activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout | Loss-of-function effects on signaling | Identify essential coreceptors |
| CRISPR point mutation | Effect of specific amino acid changes | Dissect ligand-binding interfaces |
| Knock-in tagging | Protein localization and interactions | Track coreceptor complex formation |
| Overexpression | Gain-of-function signaling | Enhance coreceptor-dependent pathways |
| RNA-seq | Transcriptional changes | Profile coreceptor-regulated gene networks |
| Proteomics | Protein expression and modifications | Map coreceptor signaling complexes |
| Co-immunoprecipitation | Protein-protein interactions | Detect coreceptor-primary receptor binding |
| Live-cell imaging | Dynamic signaling events | Visualize coreceptor recruitment |
CRISPR-based genetic screens
Genome-wide CRISPR knockout or activation screens can identify genes that modulate coreceptor activity. For example, screens in cancer cells have uncovered regulators of CD44-ErbB signaling. Such screens are powerful for discovering novel coreceptors and their downstream effectors.
Biochemical and structural approaches
Co-immunoprecipitation, surface plasmon resonance, and X-ray crystallography or cryo-EM can reveal how coreceptors bind ligands and associate with primary receptors. Structural studies of FGF-FGFR-klotho complexes have provided mechanistic insights into coreceptor function.
Transcriptomic and proteomic profiling
RNA-seq and proteomics can quantify coreceptor expression and identify signaling changes upon coreceptor perturbation. For instance, transcriptomic analysis of CD44 isoforms in breast cancer revealed differential recruitment by ErbB ligands. Proteomic profiling of klotho-deficient tissues has elucidated FGF23 signaling networks.
Functional assays and imaging
Live-cell imaging, FRET, and reporter assays can monitor coreceptor-mediated signaling in real time. Zebrafish and mouse models are used to study coreceptor function in development and disease. These methods complement genetic approaches to provide a comprehensive understanding of coreceptor biology.
How CRISPR Can Be Used to Study GO:0015026 coreceptor activity
Knockout
CRISPR knockout of coreceptor genes such as KL, CD44, or SDC2 can abolish ligand-induced signaling, providing causal evidence for their function. Knockout cell lines are valuable for dissecting downstream pathways and for drug target validation.
Point Mutation
Introducing point mutations in coreceptor genes can disrupt specific ligand-binding residues or interaction interfaces. For example, mutations in the klotho gene can impair FGF23 binding without affecting protein stability, revealing structure-function relationships.
Knock-in
Knock-in of epitope tags, fluorescent proteins, or reporter cassettes allows real-time tracking of coreceptor expression and localization. Tagged klotho or CD44 knock-in models enable imaging of coreceptor dynamics in live cells.
Overexpression
Overexpression of coreceptors can enhance signaling sensitivity and is used to study gain-of-function phenotypes. For instance, overexpression of CD44 isoforms in breast cancer cells promotes ErbB-dependent proliferation. Overexpression of klotho can protect against kidney injury in models.
How EDITGENE Supports coreceptor activity Research
Researchers studying coreceptor activity-related genes often need to determine whether a candidate gene is causally involved in ligand-dependent signaling, how specific mutations affect coreceptor function, and which downstream pathways are engaged. EDITGENE provides a comprehensive suite of CRISPR-based services to address these questions with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for coreceptor activity research.
Frequently Asked Questions About coreceptor activity
What is coreceptor activity?
Coreceptor activity (GO:0015026) is a molecular function where a protein binds a signaling molecule and cooperates with a primary receptor to initiate a cellular response.
What genes are involved in coreceptor activity?
Key genes include KL, KLB, CD44, SDC2, SCUBE1-3, CXCR4, CCR5, and F3, among others.
How does coreceptor activity differ from receptor activity?
Coreceptors do not signal alone; they require a primary receptor to transduce signals, whereas primary receptors can initiate signaling upon ligand binding.
What diseases are associated with coreceptor dysfunction?
Coreceptor dysfunction is linked to cancer, chronic kidney disease, cardiovascular disease, and inflammatory disorders.
What is the role of klotho as a coreceptor?
Klotho acts as a coreceptor for FGF23 and FGF21, forming complexes with FGFRs to regulate phosphate and vitamin D metabolism.
How is CD44 involved in coreceptor activity?
CD44 isoforms function as coreceptors for ErbB ligands and modulate signaling in breast cancer and inflammation.
What research methods are used to study coreceptor activity?
CRISPR knockout, point mutation, knock-in, overexpression, RNA-seq, proteomics, and structural biology are commonly used.
Can CRISPR screens identify new coreceptors?
Yes, genome-wide CRISPR screens can uncover novel coreceptors and modifiers of coreceptor-dependent pathways.
What is the clinical relevance of coreceptor activity?
Coreceptors are potential therapeutic targets in cancer, kidney disease, and cardiovascular disorders.
How does EDITGENE support coreceptor research?
EDITGENE offers knockout, point mutation, knock-in, overexpression, CRISPR library screening, and bioinformatics services for coreceptor genes.
Conclusion
Coreceptor activity (GO:0015026) is a fundamental molecular function that enables cells to interpret and respond to a diverse array of signals through cooperative interactions with primary receptors. From FGF-klotho complexes to CD44-ErbB and chemokine receptor systems, coreceptors provide specificity and regulatory control in development, immunity, and metabolism. Their dysfunction is implicated in major human diseases, making them attractive targets for therapeutic intervention. Advanced CRISPR-based models and functional genomics approaches are essential for dissecting coreceptor biology and translating these insights into clinical applications.
References
- 1. Chen L et al.. 2023. Structural basis for FGF hormone signalling.. Nature 618(7966):862-870 PMID: 37286607
- 2. Edmonston D et al.. 2024. FGF23 and klotho at the intersection of kidney and cardiovascular disease.. Nat Rev Cardiol 21(1):11-24 PMID: 37443358
- 3. Essner JJ et al.. 2006. Syndecan-2.. Int J Biochem Cell Biol 38(2):152-6 PMID: 16198615
- 4. Lin YC et al.. 2023. The biology of SCUBE.. J Biomed Sci 30(1):33 PMID: 37237303
- 5. Buc M et al.. 2000. [Chemokines].. Bratisl Lek Listy 101(9):507-11 PMID: 11187055
- 6. Morath I et al.. 2018. Differential recruitment of CD44 isoforms by ErbB ligands reveals an involvement of CD44 in breast cancer.. Oncogene 37(11):1472-1484 PMID: 29321661
- 7. O'Donnell JS et al.. 2023. Unraveling coagulation factor-mediated cellular signaling.. J Thromb Haemost 21(12):3342-3353 PMID: 37391097
- 8. Ho BB et al.. 2021. FGF23 signalling and physiology.. J Mol Endocrinol 66(2):R23-R32 PMID: 33338030
